Life Tech's ABI 7500 Fast Dx Platform Gets Nod for IVD Use in Europe
March 25, 2010
Life Tech's ABI 7500 Fast Dx Platform Gets Nod for IVD Use in Europe
European customers using or planning to use the 7500 Fast Dx instrument to develop in vitro diagnostic content now have a "much easier" path when submitting a complete IVD platform for regulatory approval by European authorities, a Life Tech official said.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- PCR Licensing Deal Validates Roche IP; Bolsters Life Tech's Ongoing Push into IVD Market
February 23, 2012 / PCR Insider - Epigenomics Preps for European Launch of RT-PCR Lung Cancer Dx after Clinical Trial Validation
June 24, 2010 / PCR Insider - Epigenomics Taps Synlab to Provide Colorectal Cancer Dx in Europe; Completes $44.2M Financing
April 8, 2010 / PCR Insider - Life Tech Acquisition Would Make Thermo Fisher a Leader in PCR Research Tools, Forensic Analysis
April 18, 2013 / PCR Insider - Life Technologies Launches QuantStudio Dx in Europe with Quidel C. Diff Assay
November 29, 2012 / PCR Insider